Arcus Ventures
Venture capitalNew York · Seed–Series A · 3 people tracked
Investment thesis
Arcus Ventures is a New York-based healthcare investment firm that backs oncology companies developing biopharmaceuticals, drug delivery platforms, medical devices, diagnostics, and related services. The firm's team brings backgrounds in clinical medicine, drug development, hospital management, healthcare consulting, and private equity.
Team · 3 people
from the firm's websiteFrequently asked questions
- What stage does Arcus Ventures invest at?
- Arcus Ventures invests at the Seed, Series A stages.
- What sectors does Arcus Ventures focus on?
- Arcus Ventures focuses on Biotech, Healthtech, Medical Devices.
- Where is Arcus Ventures located?
- Arcus Ventures is headquartered in New York, US.
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests €1 million to €15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
EDBI is the investment platform of Singapore's Economic Development Board and Enterprise Singapore, focusing on high-growth technology companies expanding into Singapore and Asia.